# Aspirin to Target Arterial Events in Chronic Kidney Disease

> **NCT03796156** · PHASE3 · TERMINATED · sponsor: **University of Southampton** · enrollment: 4633 (actual)

## Conditions studied

- Chronic Kidney Diseases
- Cardiovascular Diseases
- Bleeding

## Interventions

- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT03796156
- **Lead sponsor:** University of Southampton
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-25
- **Primary completion:** 2024-09-30
- **Final completion:** 2025-09-23
- **Target enrollment:** 4633 (ACTUAL)
- **Why stopped:** Planned recruitment total was not achievable within the funded timeframe
- **Last updated:** 2026-03-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03796156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03796156, "Aspirin to Target Arterial Events in Chronic Kidney Disease". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03796156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*